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Method details {#sec0001}
==============

Required equipment {#sec0002}
------------------

The MOLDI-TOF/MS used in the study was the model Autoflex III Smartbeam with nitrogen laser (VSL-337, 337 nm), which is manufactured by Bruker Inc., USA. Data of the mass spectra was collected in the reflector positive-ion mode with 25-kV acceleration voltage and 300-ns delay. The grid and guide wire voltages were set to be 90.0 and 0.15%, respectively.

Serum sample preparation {#sec0003}
------------------------

(1)Human serum was collected in sterile tubes and centrifuged at 1000 *g* for 10 min at 4 °C.(2)1 mL of the supernatant was adjusted to pH 9.8 ± 0.2 with 0.1 g/mL carbonate/bicarbonate buffer [@bib0001].(3)An incorporation of ^13^C~3~-Progesterone (15 ng/mL, Sigma-Aldrich, USA) was added as the internal standard isotope.

Progesterone extraction {#sec0004}
-----------------------

(1)The serum sample was subjected to a methanol and double-distilled water pre-equilibrated solid phase extraction column (SPE Supra-Clean 300 Å C4, PerkinElmer, USA) for the extraction of relatively hydrophobic progesterone.(2)Passing the sample through the column and discarding the flow-through, the progesterone capturing column was washed with 2 mL double-distilled water.(3)The captured progesterone was then eluted with 4 mL of methanol.(4)The eluates were subjected to centrifugal evaporation to remove the solvent.

Serum progesterone clean-up {#sec0005}
---------------------------

(1)The progesterone extracted from the serum was dissolved in 1 mL of 0.2 M pH 9.8 ± 0.2 carbonate buffer.(2)2.5 mL of hexane was added to the test tube, and the tube was subjected to vigorous shaking for 20 min [@bib0002],[@bib0003].(3)After centrifugation at 2000 rpm for 5 min, the tube was incubated at −20 °C for phase separation.(4)Discarding the frizzed lower-phase, the supernatant was transferred to a new tube for solvent evaporation by nitrogen gas.(5)The cleaned-up serum progesterone sample was finally dissolved in 5 µL of 50% ethanol prior to MALDI-TOF/MS analysis.

Sample preparation for mass spectrum {#sec0006}
------------------------------------

(1)5 µL of each serum progesterone sample described above was mixed with 1 µL of the matrix, 2,5-Dihydroxybenzoic acid (DHB, Sigma-Aldrich, USA) [@bib0004].(2)Deposited on the sample tray at room temperature. After the sample-matrix mix was dried, the tray was subjected to measurement and generally 100 laser shots were used in the analytical process. All the samples were measured in triplicate.

In the detection of progesterone in human serum samples, the signal (*m/z* 108.9) of a particular progesterone fragment was specifically used to resemble the amount of progesterone and to minimize the interference resulting from other compounds present in serum, which were co-extracted by the C4 SPE and hexane extraction [@bib0005]. A representative MALDI-TOF/MS spectrum showing the peak of fragmented serum progesterone (*m/z* = 108.9) and the isotopic standard (*m/z* = 111.9) is shown in [Fig. 1](#fig0001){ref-type="fig"}.Fig. 1MALDI-TOF MS spectrum of progesterone and ^13^C~3~-progesterone. Representative peaks at m/z 108.9 and 111.9 were obtained for progesterone and ^13^C~3~-progesterone (asterisk denotes ^13^C).Fig. 1

Funding {#sec0007}
=======

This work was supported by Research Grants: KMU-TP105E12, 105KMUOR05 and KMU-O104003 (Aim for the Top 500 Universities Grant) from Kaohsiung Medical University; 105-CCH-KMU-005 from CCH-KMU Research Project; NSYSUKMU106-P011 from NSYSU-KMU Research Project; AS-KPQ-105-TPP from Taiwan Protein Project, KMU-TC108A04 from Kaohsiung Medical University Research Center Grant and the Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.

Acknowledgements {#sec0008}
================

The authors thank S.Sheldon MT (ASCP, Retired) of Oklahoma University Medical Center Edmond for fruitful discussions and editorial assistance before submission.

Declaration of Competing Interest {#sec0008a}
=================================

The authors declare no conflicts of interest.
